Malignant lymphoma after diphenylhydantoin (dilantin) therapy
暂无分享,去创建一个
[1] E. Trell,et al. Malignant lymphogranulomatosis and anticonvulsant therapy. , 2009, Acta medica Scandinavica.
[2] R. Lukes,et al. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. , 1975, The New England journal of medicine.
[3] R. Lukes,et al. Immunologic characterization of human malignant lymphomas , 1974, Cancer.
[4] J. Clemmesen,et al. Are anticonvulsants oncogenic? , 1974, Lancet.
[5] Tashima Ck,et al. Letter: Lymphoma and anticonvulsive therapy. , 1974 .
[6] C. Tashima,et al. Lymphoma and Anticonvulsive Therapy , 1974 .
[7] S. Shapiro,et al. Diphenylhydantoin and selected congenital malformations. , 1973, The New England journal of medicine.
[8] E. Creagan,et al. Non-Hodgkin's lymphoma in childhood: epidemiologic features. , 1973, Journal of the National Cancer Institute.
[9] R. Hoover,et al. Risk of cancer in renal-transplant recipients. , 1973, Lancet.
[10] T. Waldmann,et al. Immunodeficiency disease and malignancy. Various immunologic deficiencies of man and the role of immune processes in the control of malignant disease. , 1972, Annals of internal medicine.
[11] P. Grob,et al. Immunological Abnormalities and Hydantoins , 1972, British medical journal.
[12] D. Harris,et al. Is phenytoin carcinogenic? , 1972, Lancet.
[13] T. Sorrell,et al. Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). , 1971, Lancet.
[14] R. W. Miller. Transplacental chemical carcinogenesis in man. , 1971, Journal of the National Cancer Institute.
[15] H. Kaplan. Role of Immunologic Disturbance in Human Oncogenesis: Some Facts and Fancies , 1971, British Journal of Cancer.
[16] W. Burnett,et al. Vaginal cancer after maternal treatment with synthetic estrogens. , 1971, The New England journal of medicine.
[17] R. Oates,et al. PHENYTOIN AND THE PSEUDOLYMPHOMA SYNDROME , 1971, The Medical journal of Australia.
[18] J. J. Anthony. Malignant lymphoma associated with hydantoin drugs. , 1970, Archives of neurology.
[19] P. R. Scaglione,et al. Pseudolymphoma induced by diphenylhydantoin. , 1970, The Journal of pediatrics.
[20] J. Fraumeni,et al. Hodgkin's disease in childhood: an epidemiologic study. , 1969, Journal of the National Cancer Institute.
[21] R. Gams,et al. Hydantoin-induced pseudo-pseudolymphoma. , 1968, Annals of internal medicine.
[22] S. Sommers,et al. The development of Hodgkin's disease and lymphoma during anticonvulsant therapy. , 1966, Blood.
[23] R. Schwartz,et al. Malignant Lymphomas Following Allogenic Disease: Transition from an Immunological to a Neoplastic Disorder , 1965, Science.
[24] A. Mauer,et al. DIPHENYLHYDANOIN-INDUCED HYPERSENSITIVITY REACTION. , 1965, The Journal of pediatrics.
[25] L. Ackerman,et al. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas , 1959, Cancer.